Daxor Profit Margin 2010-2011 | DXR

Current and historical gross margin, operating margin and net profit margin for Daxor (DXR) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Daxor net profit margin as of December 31, 2011 is 0%.
Daxor Annual Profit Margins
Daxor Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.041B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.877B 0.00
Quest Diagnostics (DGX) United States $16.876B 17.10
DaVita (DVA) United States $13.632B 17.63
Encompass Health (EHC) United States $9.545B 22.50
Chemed (CHE) United States $8.349B 25.66
Elanco Animal Health (ELAN) United States $5.942B 14.14
Option Care Health (OPCH) United States $4.962B 23.52
RadNet (RDNT) United States $4.431B 98.13
LifeStance Health (LFST) United States $3.057B 0.00
Amedisys (AMED) United States $3.010B 21.42
Addus HomeCare (ADUS) United States $2.427B 28.48
Astrana Health (ASTH) United States $1.978B 27.05
U.S Physical Therapy (USPH) United States $1.337B 35.14
Pennant (PNTG) United States $0.943B 38.14
Aveanna Healthcare Holdings (AVAH) United States $0.899B 0.00
Atai Life Sciences (ATAI) Germany $0.245B 0.00
Bioqual (BIOQ) United States $0.058B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00
Psychemedics (PMD) United States $0.000B 0.00